The lactate transporter MCT4 has been identified as a transcriptional target of HIF-1α [112] and a study from Saulle et al. demonstrated that in AML patients MCT4 over-expression is associated with poor prognosis [113]. The gene discussed is HIF1A; the disease is acute myeloid leukemia.